Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |